MSCG - Overview: Collagenofibrotic Glomerulopathy Confirmation, Mass Spectrometry

Aiding in the diagnosis of collagenofibrotic glomerulopathy

MSFNG - Overview: Fibronectin Glomerulopathy Confirmation, Mass Spectrometry

Aiding in the diagnosis of fibronectin glomerulopathy

TROP2 - Overview: Trophoblast Antigen 2 (TROP2) Immunostain, Semi-Quantitative Immunohistochemistry, Manual

Identification of breast and urinary cancer, among others

HPVLR - Overview: Human Papillomavirus (HPV) Low Risk, In Situ Hybridization

Detection of human papillomavirus from low-risk genotypes (6, 11)

HPVE6 - Overview: Human Papillomavirus (HPV) High-Risk E6/E7, RNA In Situ Hybridization

Stratification of oropharyngeal squamous cell carcinoma

23FBG - Overview: Fibroblast Growth Factor-23 (FGF23), In Situ Hybridization

Assessing fibroblast growth factor-23 (FGF23) expression

JCV - Overview: JC Virus Detection by In Situ Hybridization

Confirming a clinical and histopathologic diagnosis of progressive multifocal leukoencephalopathy

ALKLC - Overview: Anaplastic Lymphoma Kinase for Lung Cancer, Immunohistochemistry

Identification of anaplastic lymphoma kinase overexpression Diagnosis of inflammatory myofibroblastic tumor, anaplastic large-cell lymphoma, and for targeted therapy of lung adenocarcinoma

DLL3 - Overview: Delta-Like 3 Protein (SP347), Semi-Quantitative Immunohistochemistry, Manual, Tissue

Diagnosis of small cell lung carcinoma (SCLC), large cell neuroendocrine carcinoma (LCNEC), amongst other tumors

HPVHL - Overview: Human Papillomavirus (HPV) High/Low Risk, In Situ Hybridization

Detecting human papillomavirus for both low-risk (6, 11) and high-risk (16, 18, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, 73, and 82.) genotypes